Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

Just months after he revealed that he had been diagnosed with stage 3 non-Hodgkin Lymphoma, Dave Coulier is cancer-free!

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell ... CAR-T Therapy June 12, 2024 — A new detailed analysis of a patient's second cancer ...

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer ... While this treatment is effective, it doesn’t always prevent your cancer from coming back. If it does come back, your doctor may suggest ...

The company said that ZAMTO Cell is designed to target both CD19 and CD20, which could improve treatment efficacy.